Goldman Sachs’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-159,500
| Closed | -$15.2M | – | 6513 |
|
|
2025
Q4 | $15.2M | Hold |
159,500
| – | – | ﹤0.01% | 2648 |
|
|
2025
Q3 | $15.6M | Sell |
159,500
-5,000
| -3% | -$518K | ﹤0.01% | 2508 |
|
|
2025
Q2 | $17.7M | Buy |
164,500
+5,000
| +3% | +$506K | ﹤0.01% | 2232 |
|
|
2025
Q1 | $16.1M | Sell |
159,500
-20,000
| -11% | -$2.01M | ﹤0.01% | 2236 |
|
|
2024
Q4 | $16M | Buy |
179,500
+20,000
| +13% | +$1.76M | ﹤0.01% | 2346 |
|
|
2024
Q3 | $13.4M | Buy |
159,500
+34,000
| +27% | +$2.68M | ﹤0.01% | 2437 |
|
|
2024
Q2 | $9.66M | Sell |
125,500
-138,800
| -53% | -$10.2M | ﹤0.01% | 2540 |
|
|
2024
Q1 | $18.1M | Sell |
264,300
-41,000
| -13% | -$2.64M | ﹤0.01% | 1936 |
|
|
2023
Q4 | $17.6M | Buy |
305,300
+55,300
| +22% | +$2.95M | ﹤0.01% | 2016 |
|
|
2023
Q3 | $13.2M | Hold |
250,000
| – | – | ﹤0.01% | 2159 |
|
|
2023
Q2 | $13.5M | Buy |
+250,000
| New | +$13.1M | ﹤0.01% | 2178 |
|
|
2023
Q1 | – | Sell |
-67,300
| Closed | -$3.11M | – | 5932 |
|
|
2022
Q4 | $3.11M | Buy |
67,300
+52,500
| +355% | +$2.27M | ﹤0.01% | 3582 |
|
|
2022
Q3 | $573K | Sell |
14,800
-53,600
| -78% | -$2.15M | ﹤0.01% | 4885 |
|
|
2022
Q2 | $2.55M | Buy |
68,400
+14,800
| +28% | +$602K | ﹤0.01% | 3835 |
|
|
2022
Q1 | $2.37M | Buy |
53,600
+22,100
| +70% | +$958K | ﹤0.01% | 4107 |
|
|
2021
Q4 | $1.34M | Buy |
31,500
+2,600
| +9% | +$109K | ﹤0.01% | 4601 |
|
|
2021
Q3 | $1.25M | Sell |
28,900
-63,200
| -69% | -$2.8M | ﹤0.01% | 4573 |
|
|
2021
Q2 | $3.94M | Buy |
92,100
+56,300
| +157% | +$2.37M | ﹤0.01% | 3564 |
|
|
2021
Q1 | $1.38M | Buy |
35,800
+13,200
| +58% | +$500K | ﹤0.01% | 4348 |
|
|
2020
Q4 | $812K | Buy |
+22,600
| New | +$815K | ﹤0.01% | 4327 |
|
|
2020
Q3 | – | Sell |
-40,000
| Closed | -$1.4M | – | 5314 |
|
|
2020
Q2 | $1.4M | Hold |
40,000
| – | – | ﹤0.01% | 3717 |
|
|
2020
Q1 | $1.3M | Sell |
40,000
-67,400
| -63% | -$2.63M | ﹤0.01% | 3572 |
|
|
2019
Q4 | $4.86M | Buy |
107,400
+95,200
| +780% | +$3.98M | ﹤0.01% | 2989 |
|
|
2019
Q3 | $496K | Sell |
12,200
-1,300
| -10% | -$55.1K | ﹤0.01% | 4456 |
|
|
2019
Q2 | $580K | Sell |
13,500
-14,000
| -51% | -$538K | ﹤0.01% | 4316 |
|
|
2019
Q1 | $1.05M | Buy |
+27,500
| New | +$1.05M | ﹤0.01% | 4018 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$12K | – | 5249 |
|
|
2018
Q3 | $12K | Hold |
300
| – | – | ﹤0.01% | 5458 |
|
|
2018
Q2 | $10K | Sell |
300
-258,700
| -100% | -$7.8M | ﹤0.01% | 5543 |
|
|
2018
Q1 | $7.08M | Buy |
259,000
+258,700
| +86,233% | +$7.03M | ﹤0.01% | 2626 |
|
|
2017
Q4 | $7K | Sell |
300
-2,600
| -90% | -$71.7K | ﹤0.01% | 6228 |
|
|
2017
Q3 | $85K | Sell |
2,900
-16,000
| -85% | -$442K | ﹤0.01% | 6115 |
|
|
2017
Q2 | $524K | Sell |
18,900
-27,200
| -59% | -$722K | ﹤0.01% | 5056 |
|
|
2017
Q1 | $1.15M | Sell |
46,100
-44,100
| -49% | -$1.07M | ﹤0.01% | 4250 |
|
|
2016
Q4 | $1.95M | Sell |
90,200
-35,400
| -28% | -$772K | ﹤0.01% | 3876 |
|
|
2016
Q3 | $2.99M | Buy |
125,600
+110,900
| +754% | +$2.65M | ﹤0.01% | 3484 |
|
|
2016
Q2 | $344K | Sell |
14,700
-2,000
| -12% | -$43.3K | ﹤0.01% | 5220 |
|
|
2016
Q1 | $314K | Sell |
16,700
-81,200
| -83% | -$1.43M | ﹤0.01% | 5236 |
|
|
2015
Q4 | $1.8M | Sell |
97,900
-113,300
| -54% | -$2.03M | ﹤0.01% | 3724 |
|
|
2015
Q3 | $3.47M | Buy |
211,200
+114,200
| +118% | +$1.95M | ﹤0.01% | 3224 |
|
|
2015
Q2 | $1.72M | Sell |
97,000
-205,900
| -68% | -$3.68M | ﹤0.01% | 3991 |
|
|
2015
Q1 | $5.38M | Buy |
302,900
+111,400
| +58% | +$1.76M | ﹤0.01% | 2816 |
|
|
2014
Q4 | $2.54M | Buy |
191,500
+11,400
| +6% | +$146K | ﹤0.01% | 3605 |
|
|
2014
Q3 | $2.13M | Sell |
180,100
-100,900
| -36% | -$1.27M | ﹤0.01% | 3871 |
|
|
2014
Q2 | $3.59M | Sell |
281,000
-396,500
| -59% | -$5.16M | ﹤0.01% | 3389 |
|
|
2014
Q1 | $9.16M | Sell |
677,500
-955,300
| -59% | -$12.5M | ﹤0.01% | 2447 |
|
|
2013
Q4 | $19.6M | Buy |
1,632,800
+1,117,800
| +217% | +$13.2M | 0.01% | 1756 |
|
|
2013
Q3 | $6.05M | Sell |
515,000
-65,500
| -11% | -$709K | ﹤0.01% | 2739 |
|
|
2013
Q2 | $5.38M | Buy |
+580,500
| New | +$4.92M | ﹤0.01% | 2662 |
|
Other funds holding BSX
VCM
VPM
Goldman Sachs's BSX Position: Q1 2026 in Review
Goldman Sachs increased its Boston Scientific (BSX) stake by 14% in Q1 2026, buying an estimated $185M and bringing the position to 18,891,624 shares worth $1.19B. The position accounts for 0.14% of the portfolio, ranked #133.
Goldman Sachs first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.58B in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- Goldman Sachs held 18,891,624 shares of Boston Scientific worth $1.19B as of Q1 2026.
- Goldman Sachs bought 2,312,707 Boston Scientific shares in Q1 2026, an estimated $185M.
- Boston Scientific made up 0.14% of Goldman Sachs's portfolio in Q1 2026, its #133 holding.
- Goldman Sachs first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Boston Scientific position peaked at $1.58B in Q4 2025.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.